Rivanna Medical
  • Products
    • ProductsAccuro
    • Consumables
  • Resources
    • TrainingTraining
    • Testimonials
    • Clinical Value
    • Articles & Press
    • Upgrade
  • About
    • AboutRIVANNA
    • Leadership & BOD
    • Careers
  • Contact
    • ContactContact Us
    • Return Policy
  • Get Quote
Select Page
32% Cesarean Rate Drives Demand for First-Attempt Neuraxial Success

32% Cesarean Rate Drives Demand for First-Attempt Neuraxial Success

by RIVANNA | Jan 26, 2026 | News

The United States sees approximately 3.66 million births each year, with birth rates highest in states like Texas, California, and Florida. But behind these numbers, providers across the country are managing increasingly complex cases. More women are having children...
Solving the Blind Procedure Problem in Modern Obstetric Anesthesia

Solving the Blind Procedure Problem in Modern Obstetric Anesthesia

by RIVANNA | Jan 16, 2026 | News

In labor and delivery, every procedure brings unexpected variables — even for those who’ve spent their careers on the obstetrics floor. Unpredictability defines work in these units: a place where Dr. Hilary Gallin has spent years mastering anesthesiology’s...
RIVANNA’s 2025 Year in Review: Medical Imaging Innovation Across U.S. Healthcare

RIVANNA’s 2025 Year in Review: Medical Imaging Innovation Across U.S. Healthcare

by RIVANNA | Dec 29, 2025 | Video

2025 was a defining year for RIVANNA as we connected with anesthesiology providers, healthcare innovators, and research leaders across the United States. From clinical symposia and pitch competitions to academic conferences and a moment in Times Square, our mission...
Global Neuraxial Practices: How Regional Differences Shape Patient Outcomes

Global Neuraxial Practices: How Regional Differences Shape Patient Outcomes

by RIVANNA | Dec 17, 2025 | News

Neuraxial anesthesia is not practiced uniformly across the globe. From the operating rooms of major academic medical centers to district hospitals in resource-limited settings, the techniques, protocols, and outcomes associated with spinal and epidural anesthesia vary...

RIVANNA announces FDA clearance of Accuro 3S Needle Guide Kit

by RIVANNA | Dec 16, 2025 | Press Releases

CHARLOTTESVILLE, VA, DECEMBER 16, 2025 — RIVANNA®, developer of world-first imaging-based medical technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its Accuro® 3S Needle Guide Kit consumables. This...
« Older Entries
Next Entries »

Recent Posts

  • The Inflection Point for Neuraxial Guidance
  • Using AI to Strengthen Clinical Confidence: RIVANNA’s Will Mauldin on the Outcomes Rocket Podcast
  • RIVANNA Receives FDA 510(k) Clearance for Accuro XV Musculoskeletal Ultrasound Imaging System
  • RIVANNA nominated for MedTech Scale-Up of the Year at MedTech World Awards 2026 | North America
  • RIVANNA’s Accuro XV Demonstrates Feasibility of Musculoskeletal Imaging by Non-physician Users With Minimal Training

Products


Accuro
Accuro 3S
Accessories
Consumables
True-View Phantoms

Resources


Clinical Evidence
Testimonial
Accuro Academy
Articles & Press
True-View Phantoms

Resources


Product Documents
Service & Warranty
Software Updates
Contact Us

About

RIVANNA
Technology
Mission, Vision, & Values
Leadership, BOD, & Advisory
Careers

  • Facebook
  • X
  • YouTube
  • LinkedIn
  • Instagram
Designed by ProvenContent.com © 2026 RIVANNA MEDICAL | 2400 HUNTERS WAY | CHARLOTTESVILLE, VA 22911